Rubén Prieto‐Díaz

822 total citations
16 papers, 571 citations indexed

About

Rubén Prieto‐Díaz is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Rubén Prieto‐Díaz has authored 16 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Physiology and 3 papers in Organic Chemistry. Recurrent topics in Rubén Prieto‐Díaz's work include Adenosine and Purinergic Signaling (8 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Rubén Prieto‐Díaz is often cited by papers focused on Adenosine and Purinergic Signaling (8 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Rubén Prieto‐Díaz collaborates with scholars based in Spain, Sweden and Italy. Rubén Prieto‐Díaz's co-authors include Javier Bilbao, Alaitz Atutxa, Andrés T. Aguayo, Ana G. Gayubo, Martı́n Olazar, Roberto Aguado, Sonia Álvarez, Eddy Sotelo, Marı́a J. San José and María Majellaro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Pharmacological Reviews.

In The Last Decade

Rubén Prieto‐Díaz

14 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rubén Prieto‐Díaz Spain 10 272 160 123 89 85 16 571
Jiang Binbo China 14 136 0.5× 124 0.8× 62 0.5× 134 1.5× 50 0.6× 24 577
Juan H. Leal United States 14 208 0.8× 90 0.6× 21 0.2× 88 1.0× 34 0.4× 25 411
Yuan Rao China 8 146 0.5× 192 1.2× 67 0.5× 159 1.8× 51 0.6× 12 452
Tamer S. Ahmed Egypt 12 195 0.7× 170 1.1× 57 0.5× 65 0.7× 60 0.7× 31 416
Yunfei Song China 7 143 0.5× 83 0.5× 40 0.3× 93 1.0× 143 1.7× 24 409
Qian Huang China 12 109 0.4× 77 0.5× 96 0.8× 118 1.3× 218 2.6× 34 606
H.K. Mishra India 11 220 0.8× 180 1.1× 85 0.7× 172 1.9× 36 0.4× 16 432
Yongteng Zhao China 10 264 1.0× 265 1.7× 16 0.1× 106 1.2× 40 0.5× 10 931
Ulrich Krtschil Germany 13 333 1.2× 93 0.6× 25 0.2× 80 0.9× 131 1.5× 22 506
Kairui Liu China 16 385 1.4× 307 1.9× 118 1.0× 214 2.4× 242 2.8× 39 772

Countries citing papers authored by Rubén Prieto‐Díaz

Since Specialization
Citations

This map shows the geographic impact of Rubén Prieto‐Díaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rubén Prieto‐Díaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rubén Prieto‐Díaz more than expected).

Fields of papers citing papers by Rubén Prieto‐Díaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rubén Prieto‐Díaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rubén Prieto‐Díaz. The network helps show where Rubén Prieto‐Díaz may publish in the future.

Co-authorship network of co-authors of Rubén Prieto‐Díaz

This figure shows the co-authorship network connecting the top 25 collaborators of Rubén Prieto‐Díaz. A scholar is included among the top collaborators of Rubén Prieto‐Díaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rubén Prieto‐Díaz. Rubén Prieto‐Díaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Prieto‐Díaz, Rubén, et al.. (2025). Targeting the adenosinergic axis in cancer immunotherapy: Insights into A2A and A2B receptors and novel clinical combination strategies. Pharmacological Reviews. 77(6). 100092–100092.
2.
Prieto‐Díaz, Rubén, Hugo Gutiérrez‐de‐Terán, Luke R. Odell, et al.. (2024). Benzylhydroxamic acids as inhibitors of insulin regulated aminopeptidase (IRAP). SHILAP Revista de lepidopterología. 12. 100215–100215.
3.
Prieto‐Díaz, Rubén, María Majellaro, Jhonny Azuaje, et al.. (2024). Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents. Biomedicine & Pharmacotherapy. 173. 116345–116345. 2 indexed citations
4.
Majellaro, María, Rubén Prieto‐Díaz, Mauro Niso, et al.. (2023). Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques. Journal of Medicinal Chemistry. 66(6). 3798–3817. 5 indexed citations
5.
Stefanachi, Angela, Marialessandra Contino, Rubén Prieto‐Díaz, et al.. (2023). Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs. International Journal of Molecular Sciences. 24(7). 6581–6581. 60 indexed citations
6.
Azuaje, Jhonny, Rubén Prieto‐Díaz, María Majellaro, et al.. (2022). Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists. ACS Medicinal Chemistry Letters. 13(2). 243–249. 1 indexed citations
7.
Prieto‐Díaz, Rubén, Shiyong Neo, Le Tong, et al.. (2022). A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models. Journal for ImmunoTherapy of Cancer. 10(5). e004592–e004592. 21 indexed citations
8.
Prieto‐Díaz, Rubén, Jhonny Azuaje, María Majellaro, et al.. (2022). Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists. Journal of Medicinal Chemistry. 65(3). 2091–2106. 8 indexed citations
9.
Wang, Xuesong, Willem Jespers, Rubén Prieto‐Díaz, et al.. (2021). Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition. Scientific Reports. 11(1). 14171–14171. 9 indexed citations
10.
Prieto‐Díaz, Rubén, Willem Jespers, Jhonny Azuaje, et al.. (2020). Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. 63(14). 7721–7739. 23 indexed citations
11.
Azuaje, Jhonny, María Majellaro, Carmen R. Tubío, et al.. (2020). Catalytic performance of a metal-free graphene oxide-Al2O3 composite assembled by 3D printing. Journal of the European Ceramic Society. 41(2). 1399–1406. 13 indexed citations
12.
Jespers, Willem, Ana Oliveira, Rubén Prieto‐Díaz, et al.. (2017). Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors. Molecules. 22(11). 1945–1945. 26 indexed citations
13.
Gayubo, Ana G., Andrés T. Aguayo, Alaitz Atutxa, Rubén Prieto‐Díaz, & Javier Bilbao. (2004). Role of Reaction-Medium Water on the Acidity Deterioration of a HZSM-5 Zeolite. Industrial & Engineering Chemistry Research. 43(17). 5042–5048. 63 indexed citations
14.
Aguado, Roberto, Rubén Prieto‐Díaz, Marı́a J. San José, et al.. (2004). Defluidization modelling of pyrolysis of plastics in a conical spouted bed reactor. Chemical Engineering and Processing - Process Intensification. 44(2). 231–235. 101 indexed citations
15.
Gayubo, Ana G., Andrés T. Aguayo, Alaitz Atutxa, Rubén Prieto‐Díaz, & Javier Bilbao. (2004). Deactivation of a HZSM-5 Zeolite Catalyst in the Transformation of the Aqueous Fraction of Biomass Pyrolysis Oil into Hydrocarbons. Energy & Fuels. 18(6). 1640–1647. 142 indexed citations
16.
Aguado, Roberto, et al.. (2002). Kinetic Study of Polyolefin Pyrolysis in a Conical Spouted Bed Reactor. Industrial & Engineering Chemistry Research. 41(18). 4559–4566. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026